|
|
 |
|
Viewing report
|
|
|
|
Oman Pharmaceuticals and Healthcare Report Q4 2008
Business Monitor International, Nov 2008, Pages: 70
Executive Summary
Table: Oman Pharmaceuticals And Healthcare Industry SWOT
Oman Political SWOT Industry SWOT
Oman Economic SWOT
Oman Business Environment SWOT
Pharmaceutical Business Environment Ratings
Table: Middle East And Africa Pharmaceutical Business Environment Ratings
Limits Of Potential Returns
Risks To Realisation Of Returns
Market Summary
Regulatory Regime
Recent Regulatory Developments
Intellectual Property Regime
Table: Current IP Laws In Oman
Pricing And Reimbursement
Regional Price Harmonisation
Free Trade Agreements
Industry Developments
Epidemiology
Table: Oman Mortality Indicators, 2006
Healthcare Sector
Table: Number Of Health Centres In Oman, By Region
Table: Number and Type of Health Institutions in Oman
Private Healthcare Sector
Healthcare Reforms
Table: Healthcare Reform Targets
Medical Tourism
International Collaboration
Pharmaceutical Sector
Domestic Industry
Foreign Industry
Recent Industry Developments
International Pharmaceutical Collaboration
Table: India’s Export Of Pharmaceutical Products To The GCC Countries, 2001-2005 (US$mn)
Research And Biotechnology
Medical Devices
Industry Forecast Scenario
Overall Market Forecasts
Table: Drug Expenditure And Prescription Market Indicators, 2006-2012 (OMRmn unless otherwise stated)
Key Growth Factors – Industry
Table: Health Expenditure Indicators, 2006-2012
Key Growth Factors – Macroeconomic
Table: Oman - Economic Activity
Patented Drug Market Forecast
Table: Patented Market Indicators
Generics Market Forecast
Table: Generics Market Indicators
OTC Market Forecast
Table: OTC Market Indicators, 2006-2012 (OMRmn unless otherwise stated)
Export/Import Market Forecasts
Table: Pharmaceutical Trade Indicators, 2006-2012
Other Healthcare Data Forecasts
Table: Other Healthcare Data Forecasts
Key Risk To Forecasts
Competitive Landscape
Company Monitor
Multinationals
Novartis
Johnson & Johnson
Sanofi-Aventis
GlaxoSmithKline
Pfizer
Merck & Co
Bayer
Indigenous Manufacturers
Zynova/Oman Pharmaceutical Products (OPP)
National Pharmaceutical Industries (NPI)
Forecast Modelling
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Oman Pharmaceuticals and Healthcare Report Q1 2009
Oman Pharmaceuticals and Healthcare Report Q3 2008
Oman Pharmaceuticals and Healthcare Report Q2 2008
Oman Pharmaceuticals and Healthcare Report Q4 2009
Oman Pharmaceuticals and Healthcare Report Q2 2009
Oman Pharmaceuticals & Healthcare Report Q1 2008
Oman Pharmaceuticals and Healthcare Report Q3 2007
The Medical Device Market: Oman
Oman Commercial Banking Report Q4 2009
Kuwait Pharmaceuticals and Healthcare Report Q3 2008
Oman - Telecoms Market Overview & Statistics
Oman Insurance Report Q1 2008
|
|
|
|
